GeneTether Therapeutics (XCNQ:GTTX) FCF Yield % : -35.72 (As of May. 16, 2024)

View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, GeneTether Therapeutics's Trailing 12-Month Free Cash Flow is C$-0.62 Mil, and Market Cap is C$1.74 Mil. Therefore, GeneTether Therapeutics's FCF Yield % for today is -35.72%.

The historical rank and industry rank for GeneTether Therapeutics's FCF Yield % or its related term are showing as below:

XCNQ:GTTX' s FCF Yield % Range Over the Past 10 Years
Min: -157.23 Med: 0 Max: 0
Current: -35.72

XCNQ:GTTX's FCF Yield % is ranked worse than
69.43% of 1554 companies
in the Biotechnology industry
Industry Median: -14.48 vs XCNQ:GTTX: -35.72

GeneTether Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

GeneTether Therapeutics FCF Yield % Historical Data

The historical data trend for GeneTether Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics FCF Yield % Chart

GeneTether Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-33.07

-40.26

GeneTether Therapeutics Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial								-26.96	-22.23	-108.26	-13.30	-9.03

Competitive Comparison of GeneTether Therapeutics's FCF Yield %

For the Biotechnology subindustry, GeneTether Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeneTether Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneTether Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where GeneTether Therapeutics's FCF Yield % falls into.

GeneTether Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

GeneTether Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.624	/	1.549788
	=	-40.26%

GeneTether Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.035	*	4	/	1.549788
	=	-9.03%

GeneTether Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

GeneTether Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of GeneTether Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneTether Therapeutics (XCNQ:GTTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3

Website

https://www.genetether.com

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.

GeneTether Therapeutics (XCNQ:GTTX) Headlines

No Headlines